PIM
SGMO

Platinum Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Platinum Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-218,336
Closed -$904K – 138
2022
Q2 		$904K Hold
218,336
– – 0.03% 102
2022
Q1 		$1.27M Hold
218,336
– – 0.04% 98
2021
Q4 		$1.64M Hold
218,336
– – 0.05% 99
2021
Q3 		$1.97M Hold
218,336
– – 0.06% 100
2021
Q2 		$2.61M Hold
218,336
– – 0.06% 86
2021
Q1 		$2.74M Hold
218,336
– – 0.06% 76
2020
Q4 		$3.41M Hold
218,336
– – 0.08% 66
2020
Q3 		$2.06M Sell
218,336
-22,176
-9% -$240K 0.05% 80
2020
Q2 		$2.15M Sell
240,512
-5,328
-2% -$49.4K 0.05% 81
2020
Q1 		$1.57M Buy
245,840
+49,575
+25% +$368K 0.04% 79
2019
Q4 		$1.64M Buy
196,265
+27,680
+16% +$255K 0.03% 71
2019
Q3 		$1.53M Hold
168,585
– – 0.03% 72
2019
Q2 		$1.82M Hold
168,585
– – 0.04% 67
2019
Q1 		$1.61M Buy
168,585
+29,893
+22% +$305K 0.04% 75
2018
Q4 		$1.59M Buy
138,692
+85,792
+162% +$1.07M 0.05% 57
2018
Q3 		$897K Hold
52,900
– – 0.03% 77
2018
Q2 		$751K Buy
+52,900
New +$879K 0.02% 77

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Platinum Investment Management's SGMO Position: Q3 2022 in Review

Platinum Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2022, closing a stake of 218,336 shares — an estimated $904K sold.

Platinum Investment Management first reported a position in SGMO in Q2 2018 and held it in 17 quarters. The position peaked at $3.41M in Q4 2020. 197 funds tracked by Wall St. Rank hold SGMO as of Q3 2022.

  • Platinum Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2022 after selling out during the quarter.
  • Platinum Investment Management sold 218,336 SANGAMO THERAPEUTICS INC shares in Q3 2022, an estimated $904K.
  • Platinum Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2018 and held it in 17 quarters.
  • Platinum Investment Management's SANGAMO THERAPEUTICS INC position peaked at $3.41M in Q4 2020.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2022.

Based on Platinum Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.